Skip to main content
Caplight Logo









Agrometa

Agrometa

Private
TbilisiFrontier & Industrial Techhttps://agrometa.ge

Last Round

Grant

May 1, 2022

Total Funding Raised

$100,000

Company Overview

Agrometa operates in Frontier & Industrial Tech and is based in Tbilisi. Its latest recorded funding round was a Grant round in May 2022.

Agrometa is an agricultural technology company that provides drone-based services for crop planning, fertilization, analytics, and precision pesticide spraying to improve farming efficiency.

Sector

Frontier & Industrial Tech

Verticals

Drones & UAVs, Environmental Monitoring, Computer Vision, Vertical SaaS

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Agrometa Comparables

Compare Agrometa with similar companies based on industry and business-model similarity.

Agrometa comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AgroLab
71%
Proofminder
71%
Agremo
68%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Agrometa Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2022
SeedJun 1, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Agrometa Investors

Notable investors and investment history

Agrometa investors
InvestorRounds
Georgia's Innovation and Technology AgencyGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2022

    $80K grant from Georgia's Innovation and Technology Agency

  • Jun 1, 2021

    $20K round raised

Book a demo to see all signals

For institutional investors. Book with your work email.

Agrometa Filings

Explore SEC and related filing metadata, where available.

Agrometa filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Agrometa's valuation, stock price, and market status.

Is Agrometa a public or private company?

Agrometa is a private company.

What is the current stock price of Agrometa?

Agrometa is a private company, so its shares have no public market price. Caplight tracks Agrometa's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Agrometa worth (valuation)?

Valuation information for Agrometa is not publicly available.

Can I buy Agrometa stock?

Agrometa shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Agrometa's last funding round?

Agrometa's most recent funding round was Grant on May 1, 2022.

Who are the main investors in Agrometa?

Key investors in Agrometa include Georgia's Innovation and Technology Agency.

Will Agrometa IPO soon?

No public IPO plans have been announced for Agrometa.

How can I track Agrometa secondary market activity?

Caplight tracks bids, offers, and trades in Agrometa's shares on secondary markets.

Firmographic Details

HeadquartersTbilisi
Year Founded2022
Last FundingMay 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?